CA2056906C - Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions - Google Patents

Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions

Info

Publication number
CA2056906C
CA2056906C CA002056906A CA2056906A CA2056906C CA 2056906 C CA2056906 C CA 2056906C CA 002056906 A CA002056906 A CA 002056906A CA 2056906 A CA2056906 A CA 2056906A CA 2056906 C CA2056906 C CA 2056906C
Authority
CA
Canada
Prior art keywords
formula
compound
stress
compounds
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002056906A
Other languages
English (en)
French (fr)
Other versions
CA2056906A1 (en
Inventor
Peter-Eugene Keane
Alberto Bianchetti
Jacques Simiand
Tiziano Croci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of CA2056906A1 publication Critical patent/CA2056906A1/en
Application granted granted Critical
Publication of CA2056906C publication Critical patent/CA2056906C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002056906A 1990-12-04 1991-12-04 Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions Expired - Lifetime CA2056906C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9015171 1990-12-04
FR9015171A FR2669821A1 (fr) 1990-12-04 1990-12-04 Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.

Publications (2)

Publication Number Publication Date
CA2056906A1 CA2056906A1 (en) 1992-06-05
CA2056906C true CA2056906C (en) 1998-04-28

Family

ID=9402882

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002056906A Expired - Lifetime CA2056906C (en) 1990-12-04 1991-12-04 Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions

Country Status (13)

Country Link
US (1) US5270341A (https=)
EP (1) EP0489640B1 (https=)
JP (1) JP2610735B2 (https=)
AT (1) ATE143592T1 (https=)
AU (1) AU653968B2 (https=)
CA (1) CA2056906C (https=)
DE (1) DE69122480T2 (https=)
DK (1) DK0489640T3 (https=)
FR (1) FR2669821A1 (https=)
HU (1) HU207793B (https=)
IE (1) IE76322B1 (https=)
MX (1) MX9102365A (https=)
SG (1) SG47450A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EP1623705A1 (en) * 2004-07-09 2006-02-08 Sanofi-Aventis Use of phenylethanolaminotetralines for preparing anxiolytic drugs
FR2890862B1 (fr) * 2005-09-19 2008-01-25 Sanofi Aventis Sa Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH637363A5 (en) * 1977-11-24 1983-07-29 Sandoz Ag Process for preparing novel 2-aminotetralins
FR2584712B1 (fr) * 1985-07-10 1987-11-27 Midy Spa Phenylethanolamines a activite lipolytique, un procede pour leur preparation et compositions pharmaceutiques en contenant
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
US4927955A (en) * 1987-08-12 1990-05-22 Sanofi Process for the O-alkylation of N-(hydroxy)aralkylphenylethanolamines
DE3872100T2 (de) * 1987-08-12 1993-01-28 Sanofi Elf Verfahren zur herstellung von phenylaethanolaminotetralinen.
EP0452390B1 (en) * 1989-01-09 1994-10-26 The Upjohn Company Halo substituted aminotetralins
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
DE69028877T2 (de) * 1989-06-13 1997-02-27 Sanofi Sa Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden

Also Published As

Publication number Publication date
EP0489640B1 (fr) 1996-10-02
DE69122480T2 (de) 1997-04-24
JPH0525040A (ja) 1993-02-02
HUT59595A (en) 1992-06-29
JP2610735B2 (ja) 1997-05-14
SG47450A1 (en) 1998-04-17
US5270341A (en) 1993-12-14
CA2056906A1 (en) 1992-06-05
DK0489640T3 (da) 1997-02-17
FR2669821B1 (https=) 1994-12-09
IE914195A1 (en) 1992-06-17
AU653968B2 (en) 1994-10-20
HU207793B (en) 1993-06-28
IE76322B1 (en) 1997-10-22
DE69122480D1 (de) 1996-11-07
EP0489640A1 (fr) 1992-06-10
FR2669821A1 (fr) 1992-06-05
AU8839591A (en) 1992-06-11
HU913800D0 (en) 1992-02-28
ATE143592T1 (de) 1996-10-15
MX9102365A (es) 1992-09-01

Similar Documents

Publication Publication Date Title
US4273774A (en) Central nervous system compositions and method
EP0244080A2 (en) Medicament for the treatment of obesity
KR102372194B1 (ko) Lsd1 억제제를 이용한 다발성 경화증의 치료방법
JPH0144684B2 (https=)
JPS58154511A (ja) 体重減少剤
NZ264774A (en) Use of fluoxetine, venlafaxine, milnacipran and duloxetine with a synergist in pharmaceutical compositions
WO1994025016A1 (en) Novel medical use for gaba agonists
HUP9904362A2 (hu) Eljárás felső légúti allergiás tünetek kezelésére hisztamin H1 és H3 receptor-antagonisták kombinációjával
HU214321B (hu) Eljárás tramadol-N-oxid-származék, enantiomerjei és ezeket hatóanyagként tartalmazó gyógyszerkészítmények előállítására
JPH07300417A (ja) 抗うつまたは抗パーキンソン病薬
AU737590B2 (en) Use of mirtazapine for treating sleep apneas
KR100372243B1 (ko) 심장-부정맥을 치료하기 위한 조성물 및 방법
US4336260A (en) Method and compositions using 1-aryl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid for treating depression
CA2056906C (en) Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions
JPH05509293A (ja) 不整脈および発作の治療における５―ｈｔ４受容体拮抗剤の使用
EP0215200B1 (en) Use of sulfanilamido quinoxalines in the treatment of neoplastic diseases
Farmer et al. Comparative beta-adrenoceptive stimulant properties of salbutamol (AH 3365), orciprenaline and soterenol (MJ 1992)
US5945455A (en) Amine and amidine containing compounds as weight reducing agents
JP2001500526A (ja) 粘液溶解剤としての２−メチル−チアゾリジン−２，４−ジカルボン酸の使用
JPH0651669B2 (ja) 抗炎症及び鎮痛活性を有する化合物及び組成物
JPS6081127A (ja) 食欲抑制剤
US3885045A (en) Therapeutic composition containing 1-(2-hydroxy-2-indanyl)-propylamine
US3553331A (en) Pharmaceutical compositions and methods utilizing 4-alkyl-1,4-dimethycyclo-hexylamines and 4-alkyl-1,4-dimethylcyclohexanemethylamines
US3308019A (en) Alkyl-n-[alpha, alpha-dimethyl-beta-(p-halophenyl)-ethyl]-carbamates and compositions thereof
US20040242701A1 (en) Amines as ant-alcoholism agents

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry